New Zynex Leadership Responds to Indictment of Former Executives

Core Viewpoint - Zynex, Inc. is addressing the federal indictments of two former executives while emphasizing its commitment to integrity and compliance under new leadership [1][2][3]. Company Response to Indictments - The individuals indicted are no longer with Zynex and do not influence current operations. Following the indictments, Thomas Sandgaard was removed as director and Chair of the Board [2]. - Zynex has not faced any criminal or civil charges [2]. Leadership and Compliance Overhaul - Over the past six months, Zynex has completely overhauled its leadership, compliance program, billing practices, and operational controls [3]. - The company is under new leadership and is committed to maintaining high integrity in its business practices with rigorous compliance oversight [3]. Cooperation with Authorities - Zynex has cooperated extensively with the Department of Justice and other regulators while seeking a long-term resolution to ongoing investigations [3]. Bankruptcy Proceedings - The company is currently reorganizing under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas, Houston Division [3]. Commitment to Future Operations - Zynex aims to build trust through transparency, integrity, and compliance while focusing on improving the quality of life for patients suffering from pain and other conditions [4].